Relaxed Regulations for Clinical Trials of Low-risk Medical Devices, Including AI, in South Korea
SEOUL, Jan. 10 (Korea Bizwire) – The South Korean Ministry of Food and Drug Safety (MFDS) has announced that clinical trials for low-risk medical devices, including medical artificial intelligence (AI), can now be conducted without the need for clinical plan approval from the MFDS. This change will also allow trials to be conducted outside of designated [...]